| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.01 | 1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |